India's Potential Foreign Investors Face Hurdle In High Court Setting Prices
This article was originally published in PharmAsia News
Executive Summary
Potential foreign investors in India's pharmaceutical industry are finding a recent announcement easing restrictions on some investments had little effect as the regulatory system and now the Supreme Court is about to become the price-control policymaker.